Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Alzheimer's Medication Trials

Boston, Massachusetts

Alzheimer's medication trials in Boston, MA

10 Alzheimer's medication studies are recruiting participants at sites in Boston as of November 17, 2026, according to ClinicalTrials.gov. Alzheimer's Medication Trials can help you understand your options and connect with a study team.

Call (888) 927-5916
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Boston at a glance

  • 10 studies are recruiting at a site in Boston.
  • By phase: Phase 1 (1), Phase 1/2 (2), Phase 2 (4), Phase 3 (3).
  • By sponsor: industry (6), university, hospital or other (4).
  • Most recent update to one of these records: November 6, 2026.

Studies recruiting in Boston

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

    • Phase 3
    • Ages 55 to 80
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Adams Clinical Boston
    Registry record
    NCT07717411 · updated
  2. A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia

    • Phase 2
    • Ages 55 and older
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Study site
    Tufts University School of Medicine
    Registry record
    NCT06651567 · updated
  3. A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    Tufts Medical Center - 800 Washington St - PPDS
    Registry record
    NCT06585787 · updated
  4. Alzheimer's Tau Platform: Master Protocol

    • Phase 2
    • Ages 50 to 80
    • All sexes
    Sponsor
    Paul S. Aisen
    Study site
    Brigham and Women's Hospital Center for Alzheimer Research and Treatment
    Registry record
    NCT06957418 · updated
  5. Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

    • Phase 2
    • Ages 55 to 80
    • All sexes
    Sponsor
    Lighthouse Pharmaceuticals, Inc.
    Study site
    Adams Clinical Boston
    Registry record
    NCT06847321 · updated
  6. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eidos Therapeutics, a BridgeBio company
    Study sites
    Boston University (BU) School of Medicine · Brigham and Women's Hospital · Massachusetts General Hospital
    Registry record
    NCT06563895 · updated
  7. Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease

    • Phase 2
    • Ages 60 to 85
    • All sexes
    Sponsor
    Brigham and Women's Hospital
    Study site
    Center for Alzheimer Research and Treatment, Brigham and Women's Hospital
    Registry record
    NCT06489548 · updated
  8. PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases

    • Phase 1/2
    • Ages 18 to 85
    • All sexes
    Sponsor
    Brigham and Women's Hospital
    Study site
    Brigham MS Center, 60 Fenwood Road
    Registry record
    NCT02649985 · updated
  9. Assess Fibrin in Brains With AD/ADRD

    • Phase 1/2
    • Ages 55 to 90
    • All sexes
    Sponsor
    Massachusetts General Hospital
    Study site
    Massachusetts General Hospital
    Registry record
    NCT05336695 · updated
  10. Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation

    • Phase 1
    • Ages 55 to 75
    • All sexes
    Sponsor
    General Biophysics LLC
    Study site
    Brigham and Women's Hospital
    Registry record
    NCT06945614 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Boston, MA on ClinicalTrials.gov.

Ask about studies near Boston

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Massachusetts

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.

Alzheimer's Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5916

or send a short form

How should we reach you?

Call